The IKBKG gene (IKBKG stands for "Inhibitor Of Nuclear Factor Kappa B Kinase Regulatory Subunit Gamma", also called NEMO gene) is a protein coding gene located on chromosome Xq28. The IKBKG gene encodes the regulatory subunit of the "Inhibitor of KappaB Kinase (IKK) complex", which phosphorylates inhibitors of NF-kappa-B, leading to dissociation of the inhibitor/NF-kappa-B complex, degradation of the inhibitor and activation of NF-kappaB. This activates a group of genes involved in inflammation, immunity, cell survival, and other signaling pathways.
IKBKG Gene
DefinitionThis section has been translated automatically.
General informationThis section has been translated automatically.
Mutations in this gene are associated with incontinentia pigmenti (OMIM: 308300).
Furthermore, mutations are associated with the clinical picture of "An(hypo)hidrotic ectodermal dysplasia with immunodeficiency 1(OMIM: 300291), as well as with various other types of immunodeficiencies (immunodeficiency 1).
A pseudogene very similar to this locus is located in an adjacent region of the X chromosome.
LiteratureThis section has been translated automatically.
- Doffinger R et al (2001) X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappa-B signaling. Nature Genet. 27: 277-285.
- Heller S et al (2020) T cell impairment is predictive for a severe clinical course in NEMO deficiency. J Clin Immun 40: 421-434.
- Jain A et al . Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohidrotic ectodermal dysplasia. Nature Immun 2: 223-228.
- Orange JS et al (2002) Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations. J Clin Invest 109: 1501-1509.
- Orange JS et al (2004) The presentation and natural history of immunodeficiency caused by nuclear factor kappa-B essential modulator mutation. J Allergy Clin Immun 113: 725-733.
- Roberts CML et al (2010) A novel NEMO gene mutation causing osteopetrosis, lymphoedema, hypohidrotic ectodermal dysplasia and immunodeficiency. Europ J Pediat 169: 1403-1407.
- The International Incontinentia Pigmenti Consortium. Genomic rearrangement in NEMO impairs NF-kappa-B activation and is a cause of incontinentia pigmenti. Nature 405: 466-472.